Clinical trial
A Phase 4 Randomized, Double-Blind, Placebo Controlled Methodology Study to Evaluate the Time of Onset of AntiDepressant Response in Subjects With Major Depressive Disorder
NCT00406952 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 4 Randomized, Double-Blind, Placebo Controlled Methodology Study to Evaluate the Time of Onset of AntiDepressant Response in Subjects With Major Depressive Disorder
- Lead sponsor
- Pfizer
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- August 31, 2007
- Enrollment
- 165 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
depressive disorder, major